Empowering Biotech and Life Sciences

PSG Life Sciences is dedicated to guiding biotech and life sciences companies through the complex lifecycle of our industry. Our mission is to empower companies in preclinical research by providing expert marketing, business development, and sales consulting services tailored to their unique needs. Also, as a HubSpot Gold Service provider, we specialize in optimizing CRM strategies to drive growth and deliver measurable results.

Discover Our Mission

The Biotech CRO

Growth Playbook

Download

Biotech HubSpot Implementation Guide

Download

The Guide to Scientific Lead Management

Download

Discover our Solutions

Start

Unlock the potential of your biotech venture with tailored commercialization strategies and investor insights.

Grow

Established life sciences product and service companies often face inflection points in scaling their sales and marketing efforts. PSG provides the tools and expertise needed to break through these challenges.

Prepare and Expand

PSG Life Sciences is dedicated to guiding biotech and life sciences companies through the complexities of acquisitions and mergers

Brands we work with

Why Pre-Revenue Biotech Tool Companies Need a Commercialization Partner Before They Have Revenue

How founders of reagent, kit, assay, instrument, and software tool companies use commercial strategy to raise their next round and reach first revenue faster. Most biotech tool companies are founded on a genuine technical advance: a more sensitive assay, a cleaner...

Why HubSpot Life Sciences Pro Is the Best CRM Implementation and Management Solution for Life Sciences Companies

Choosing a CRM is only the first step. The more important question is whether the system will be designed, implemented, and managed around the way your life sciences company actually operates. Biotech companies, CROs, CDMOs, research-tool manufacturers, reagent...

Key Factors in Choosing a Biotech CRM

What to evaluate when your commercial model runs on both direct and distributor sales, as well as a long, scientific buying cycle.Choosing a CRM is one of the highest-leverage commercial decisions an early biotech makes, and one of the easiest to get wrong because...

What to Look for in a Life Sciences CRM Partner

A practical guide to evaluating CRM implementation partners for complex scientific sales cycles, including strategy, integration, and the part everyone underestimates: adoption. Most life sciences companies choosing a CRM partner end up talking to a marketing agency....

The Growth Engine Most Life Science Companies Ignore: Customer Referrals

Why referrals and customer mobility, not brand marketing alone, drive new-account growth in life science markets, and how to build the ask into your sales playbook, battle cards, and CRM automation. When I led commercial efforts at GENEWIZ, we made a deliberate bet:...

CNS and Neurodegeneration Biomarkers: In This Market, Speed Is the Product

Ultra-sensitive multiplex immunoassay technology now detects low-abundance biomarkers in complex matrices like cerebrospinal fluid, enabling earlier-stage Alzheimer’s and neurodegenerative disease research that simply wasn’t possible a few years ago. p-Tau 217 went...

Next-Generation Sequencing: The Growth Moved. Did Your Sales Strategy Move With It?

NGS isn’t "next gen" anymore. The core sequencing instrument market is dominated by a small number of established platform vendors, and that’s not changing. If your growth strategy still depends on competing for that instrument-level attention, you’re fighting a...

Lab Automation and Decentralized Labs: Your Customers’ Labs Changed. Has Your Pricing Model?

Labs are getting smaller, more automated, and more distributed. Instruments are shrinking and handling more of the manual work themselves. Research hubs outside the traditional life science centers are standing up modular, flexible labs instead of building large...

Pharmacodynamic Biomarker Services: The Fastest Path to Revenue Isn’t the Biotech Sponsor

Biomarker-guided drug development is now structural, not a passing trend; pharma and biotech companies rely on PD biomarkers to select doses, prove mechanism of action, and stratify patients across oncology, immunology, neurology, and rare disease. If you provide...

Gene Editing and CRISPR Reagents: One Market, Two Very Different Sales Cycles

Genome editing is moving from a research tool into therapeutic development pipelines, and that shift is creating real, recurring demand for guide RNAs, delivery reagents, and validation kits. It’s also creating a commercial trap for reagent companies that don’t...

PSG Life Sciences is committed to helping you achieve your business goals. Whether you’re scaling your start-up, growing revenue, preparing for acquisition, or optimizing a merger, we have the tools and expertise to guide you every step of the way.

Empowering Biotech and Life Sciences

The Biotech CRO

Growth Playbook

Biotech HubSpot Implementation Guide

The Guide to Scientific Lead Management

Discover our Solutions

Brands we work with

Brands we work with

Partner with PSG Life Sciences

PSG Life Sciences is committed to helping you achieve your business goals. Whether you’re scaling your start-up, growing revenue, preparing for acquisition, or optimizing a merger, we have the tools and expertise to guide you every step of the way.